HC Wainwright Brokers Increase Earnings Estimates for ALDX
Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Free Report) – Investment analysts at HC Wainwright increased their FY2029 earnings estimates for shares of Aldeyra Therapeutics in a research report issued to clients and investors on Monday, May 19th. HC Wainwright analyst M. Caufield now expects that the biotechnology company will post earnings of $1.10 per share for […]
